Publications by authors named "David Heimansohn"

Claim this Profile
A
A study assessing the performance, safety, and durability of a new bioprosthetic aortic valve after up to seven years in the heart: a plain language summary.
Thomas Beaver, Joseph E Bavaria, Bartley Griffith, Lars G Svensson, Philippe Pibarot, David A Heimansohn

Future Cardiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven-Year Results for RESILIA Tissue in Bicuspid Aortic Valve Replacement Patients: Age and Valve Size Considerations.
Michael Salna, Joseph E Bavaria, David Heimansohn, Thomas Beaver, Bartley Griffith

Interdiscip Cardiovasc Thorac Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of small size sutureless prostheses: results for 241 patients from an international registry.
Giuseppe Santarpino, Roberto Lorusso, Giovanni Concistrè, Josè Cuenca Castillo, Vincenzo Argano, David Heimansohn

J Cardiothorac Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year comparison of clinical and echocardiographic outcomes of pure aortic stenosis with pure aortic regurgitation or mixed aortic valve disease in the COMMENCE trial.
Vinod H Thourani, John D Puskas, Bartley Griffith, Lars G Svensson, Philippe Pibarot, David Heimansohn

JTCVS Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis.
Thomas Beaver, Joseph E Bavaria, Bartley Griffith, Lars G Svensson, Philippe Pibarot, David A Heimansohn

J Thorac Cardiovasc Surg· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does valve size impact hemodynamic, left ventricular mass regression, and prosthetic valve deterioration with a sutureless aortic valve?
Gabriel S Aldea, Christopher R Burke, Theodor Fischlein, David A Heimansohn, Axel Haverich

J Thorac Cardiovasc Surg· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mid-term outcomes of the COMMENCE trial investigating mitral valve replacement using a bioprosthesis with a novel tissue.
David A Heimansohn, Craig Baker, Evelio Rodriguez, Hiroo Takayama, Francois Dagenais

JTCVS Open· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement With RESILIA Tissue.
Joseph E Bavaria, Bartley Griffith, David A Heimansohn, Jacek Rozanski, Douglas R Johnston

Ann Thorac Surg· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcarotid versus transthoracic access for transcatheter aortic valve replacement: A propensity-matched analysis.
Keith B Allen, Adnan K Chhatriwalla, John Saxon, James Hermiller, David Heimansohn

J Thorac Cardiovasc Surg· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply from authors: Transcarotid trumps transapical/direct aortic access for transcatheter aortic valve replacement-It's a no brainer!
Keith B Allen, Adnan K Chhatriwalla, John Saxon, James Hermiller, David Heimansohn

J Thorac Cardiovasc Surg· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary Evaluation of a Novel Polymeric Valve Following Surgical Implantation for Symptomatic Aortic Valve Disease.
Dean J Kereiakes, Geoff A Answini, Steven J Yakubov, Balaj Rai, J Michael Smith, David Heimansohn

JACC Cardiovasc Interv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trials Are Needed for Transcatheter Mitral Valve Replacement.
Jason H Rogers, Paul Sorajja, Vinod H Thourani, Rahul Prakash Sharma, Bassem Chehab, David Heimansohn

JACC Cardiovasc Interv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcarotid Versus Subclavian/Axillary Access for Transcatheter Aortic Valve Replacement With SAPIEN 3.
Eric Kirker, Ethan Korngold, Robert W Hodson, Brandon M Jones, Raymond McKay, David Heimansohn

Ann Thorac Surg· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
Raj R Makkar, Wen Cheng, Ron Waksman, Lowell F Satler, Tarun Chakravarty, David Heimansohn

Lancet· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.
David A Wood, Zvonimir Krajcer, Janarthanan Sathananthan, Neil Strickman, Chris Metzger, David Heimansohn

Circ Cardiovasc Interv· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective US investigational device exemption trial of a sutureless aortic bioprosthesis: One-year outcomes.
Rakesh M Suri, Hoda Javadikasgari, David A Heimansohn, Neil J Weissman, Gorav Ailawadi

J Thorac Cardiovasc Surg· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
Michael J Mack, William T Abraham, JoAnn Lindenfeld, Steven F Bolling, Ted E Feldman, David A Heimansohn

Am Heart J· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue.
John D Puskas, Joseph E Bavaria, Lars G Svensson, Eugene H Blackstone, Bartley Griffith, David A Heimansohn

Eur J Cardiothorac Surg· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
North American trial results at 1 year with the Sorin Freedom SOLO pericardial aortic valve.
David Heimansohn, Eric E Roselli, Vinod H Thourani, Shaohua Wang, Pierre Voisine

Eur J Cardiothorac Surg· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.
Ted Feldman, Saibal Kar, Sammy Elmariah, Steven C Smart, Alfredo Trento, David Heimansohn

J Am Coll Cardiol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ABLATE Trial: Safety and Efficacy of Cox Maze-IV Using a Bipolar Radiofrequency Ablation System.
Jonathan M Philpott, Christian W Zemlin, James L Cox, Mack Stirling, Michael Mack, David A Heimansohn

Ann Thorac Surg· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery.
Steven J Yakubov, David H Adams, Daniel R Watson, Michael J Reardon, Neal S Kleiman, David Heimansohn

J Am Coll Cardiol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and haemodynamic outcomes in 804 patients receiving the Freedom SOLO stentless aortic valve: results from an international prospective multicentre study.
Herko Grubitzsch, Shaohua Wang, Klaus Matschke, Mattia Glauber, David Heimansohn

Eur J Cardiothorac Surg· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery.
Michael J Reardon, David H Adams, Joseph S Coselli, G Michael Deeb, Neal S Kleiman, David Heimansohn

J Thorac Cardiovasc Surg· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-center experience with the Sorin Mitroflow pericardial aortic valve: hemodynamics up to five years.
David A Heimansohn, Robert J Robison, Peter Walts, Christopher T Salerno, Bill Dolman

J Heart Valve Dis· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis